D-0397-2021 Class I Terminated

Recalled by Acella Pharmaceuticals, LLC — Alpharetta, GA

FDA drug recall D-0397-2021 was initiated by Acella Pharmaceuticals, LLC on Apr 29, 2021 and is designated Class I. Reason for recall: Subpotent Drug The recall status is terminated (terminated Mar 13, 2024). Affected quantity: 154,726 bottles.

Recall details

Product Type
Drugs
Report Date
Jun 2, 2021
Initiation Date
Apr 29, 2021
Termination Date
Mar 13, 2024
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
154,726 bottles

Product description

NP Thyroid 60 Thyroid Tablets, USP 1 grain (60 mg) 100-count bottles, Rx Only Manufactured For: Acella Pharmaceuticals, LLC Alpharetta, GA 30005, NDC 42192-330-01

Reason for recall

Subpotent Drug

Distribution pattern

Nationwide within the United States including Puerto Rico

Code information

Lots: M330D20-1, M330D20-2 Exp. 03/31/2022; M330J19-2A, M330J19-4A , M330J19-5A, M330J19-6A, M330J19-7A, M330J19-9A Exp. 08/31/2021; M330K19-10, M330K19-1A, M330K19-9 Exp. 09/30/2021

Source

Dataset
openFDA drug recall enforcement reports
FDA record
This recall in openFDA (JSON)
Enforcement Report
Search FDA's Enforcement Report for D-0397-2021
openFDA file date
Nov 10, 2026
Loaded by RegDataLab
Nov 11, 2026

These dates say when openFDA published the data file and when RegDataLab last loaded it.

Source: openFDA record for D-0397-2021. Report a data issue: hello@regdatalab.com.